SAGE THERAPEUTICS INC shareholders Q2 2023

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 224 filers reported holding SAGE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

SAGE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Finepoint Capital LP 357,765$16,822,1105.82%
Palo Alto Investors LP 859,517$40,414,4893.26%
Boxer Capital, LLC 1,094,000$51,4402.39%
DAFNA Capital Management LLC 180,306$8,477,9882.32%
Bellevue Group AG 3,114,375$146,437,9132.09%
Saturn V Capital Management LP 70,559$3,317,6841.84%
SPHERA FUNDS MANAGEMENT LTD. 128,000$6,018,5600.94%
Artal Group S.A. 500,000$23,5100.73%
Parkman Healthcare Partners LLC 70,033$3,292,9520.57%
Integral Health Asset Management, LLC 80,000$3,761,6000.47%
Casdin Capital, LLC 90,000$4,231,8000.37%
Aristotle Atlantic Partners, LLC 197,626$9,292,3750.35%
Simplify Asset Management Inc. 50,030$2,352,4110.31%
READYSTATE ASSET MANAGEMENT LP 82,568$3,882,3470.29%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 20,000$939,4000.29%
PDT Partners, LLC 40,531$1,905,7680.26%
Neo Ivy Capital Management 10,290$4840.26%
Hennion & Walsh Asset Management, Inc. 81,233$3,8200.23%
EASTERLY INVESTMENT PARTNERS LLC 51,121$2,403,7090.21%
EFG Asset Management (North America) Corp. 21,003$987,2460.21%
External links

This page lists SAGE THERAPEUTICS INC's shareholders in Q2 2023. To view SAGE THERAPEUTICS INC's shareholder history, click here.